GLP-1 Use Linked To Lower MS Relapse Rates, Study Suggests

GLP-1 Use Linked To Lower MS Relapse Rates, Study Suggests The author of the real-world study noted that GLP-1 agents might modulate neuroinflammation and neuronal survival through the gut-brain axis, which could contribute to the lower rates of relapse activity and steroid use, reduced incidence of optic neuritis, and fewer demyelinating events, MedPage Today reported. https://kffhealthnews.org/morning-breakout/pharma-and-tech-102726/